Atlas Trials

Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Clinical trial NCT05780567 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05780567
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-03-30
Primary completion
2026-12-01
Enrollment
1946

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.